(Q30604572)

25 June 2017

title

Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool (English)

1 reference

25 June 2017

0 references

Weissig V V

1

1 reference

25 June 2017

Babich J

series ordinal

2

1 reference

25 June 2017

Torchilin V V

series ordinal

3

1 reference

25 June 2017

publication date

1 October 2000

1 reference

25 June 2017

published in

Colloids and Surfaces B

1 reference

25 June 2017

volume

18

1 reference

25 June 2017

issue

3-4

1 reference

25 June 2017

page(s)

293-299

1 reference

Delivery of diagnostic agents: achievements and challenges

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Liposomal Gd-DTPA: preparation and characterization of relaxivity

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Biodistribution and clearance of liposomal gadolinium-DTPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Manganese-based liposomes. Comparative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Terminal-modified polylysine-based chelating polymers: highly efficient coupling to antibody with minimal loss in immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: targeted MRI contrast agents for the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates

1 reference

https://api.crossref.org/works/10.1016%2FS0927-7765%2899%2900155-1

7 January 2021

10.1016/S0927-7765(99)00155-1

Identifiers

DOI

1 reference

25 June 2017

1 reference